Uloric Whistleblower Lawsuits Allege the Manufacturer Withheld Dangerous Side Effect Information

First introduced onto the market in February 2009, Uloric (febuxostat), manufactured by Takeda Pharmaceuticals, was the first medication formulated to treat gout in more than four decades. However, not long after its introduction, many individuals have come forward with reports of serious side effects from using the drug. Uloric and the treatment of gout Uloric…

Read More

Ocaliva Dosage Errors Prompt the FDA to Require New Black Box Warning

FDA officials have now added a boxed warning label to obeticholic acid (Ocaliva), a liver disease medicine, in order to emphasize the proper dosing patients with rare chronic liver disease should follow. The FDA announcement states that the designated daily dosage for obeticholic acid, manufactured by Intercept Pharmaceuticals, has been incorrect. Instead, the dosage has…

Read More

Nuplazid Produced Worsening Conditions for Many Users

Anti-psychotic drug Nuplazid (pimavanserin) is manufactured by Acadia pharmaceuticals and approved by the Federal Drug Administration (FDA) for treating Parkinson’s disease patients with debilitating psychosis. The process of approval used for Nuplazid allowed an expedited pharmaceutical safety review by categorizing this drug as a breakthrough therapy. Instituted by Congress in 2012, this breakthrough therapy classification…

Read More

Warning: These Teething Medicines Are Unsafe for Your Baby

The U.S. Food and Drug Administration (FDA) is warning consumers about an over-the-counter teething medication for infants and children under the age of two that could be harmful. The agency says that products containing benzocaine are dangerous and pose a serious risk to infants and children under two. Benzocaine is used to treat sore gums,…

Read More

Several Diabetes Drugs May Cause Increased Risk of Toe Amputation

Recent findings provided by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) detail the connection between the use of several diabetes drugs and the elevated risk of toe amputation. The diabetes drugs that pose this serious risk to patients are classified as sodium-glucose cotransporter-2 (SGLT2) inhibitors used to treat individuals with…

Read More

What Are the Risks and Adverse Effects from Dry Needling?

Dry needling is a therapeutic option for pain relief that some physical therapists, chiropractors, and sports medicine doctors use to treat pain and increase range of motion in injured patients. However, when this therapy is performed improperly or in an unsterile manner, there are potential risks and side effects that can be serious and cause…

Read More